周建中,陈泽民,危北海.慢性胃炎中西医结合诊断、辩证和疗效标准(试行方案)[J].中西医结合杂志,1990,10(5):318-319.

中国中西医结合学会消化病专业委员会.慢性胃炎中西医结合诊治方案(2003,莺庆)[J].中国中西医结合杂志,2005,25(2):172-175.

中国中西医结合学会消化系统疾病专业委员会.慢性胃炎中西医结合诊疗共识意见(2011年天津)[J].中国中西医结合杂志,2012,32(6):738-743.

中华医学会消化病学分会.中国慢性胃炎共识意见[J].胃肠病学,2013,18(1):24-36.

Dixon M F,Genta R M,Yardley J H,et al.Classification and grading of gastritis.The updated Sydney System.International Workshop on the Histopathology of Gastritis,Houston 1994[J].Am J Surg Pathol,1996,20(10):1161-1181.

Misiewicz J J.The Sydney System:a new classification of gastritis Introduction[J].J Gastroenterol Hepatol,1991,6(3):207-208.

Plummer M,Buiatti E,Lopez G,et al.Histological diagnosis of precancerous lesions of the stomach:a reliability study[J].Int J Epidemiol,26(4):716-720.

Ohata H,Kitauchi S,Yoshimura N,et al.Progression of chronic atrophic gastritis associated with Helicobacter pylori infection increases risk of gastric cancer[J].Int J Cancer,2004,109(1):138-143.

González C A,Figueiredo C,Lic C B,et al.Helicobacter pylori cagA and vacA genotypes as predictors of progression of gastric preneoplastic lesions:a long-term follow-up in a high-risk area in Spain[J].Am J Gastroenterol,2011,106(5):867-874.

Sharma P K,Suri T M,Venigalla P M,et al.Atrophic gastritis with high prevalence of Helicobacter pylori is apredominant feature in patients with dyspepsia in a high altitude area[J].Trop Gastroenterol,2014,35(4):246-251.

de Vries A C,van Grieken N C,Looman C W,et al.Gastric cancer risk in patients with premalignant gastric lesions:a nationwide cohort study in the Netherlands[J].Gastroenterology,2008,134(4):945-952.

Song H,Ekheden I G,Zheng Z,et al.Incidence of gastric cancer among patients with gastric precancerous lesions:observational cohort study in a low risk Western population[J].BMJ,2015,351:h3867.

Redéen S,Petersson F,J9nsson K A,et al.Relationship of gastroscopic features to histological findings in gastritis and Helicobacter pylori infection in a general population sample[J].Endoscopy,2003,35(11):946-950.

Lee J Y,Kim N,Lee H S,et al.Correlations among endoscopic,histologic and serologic diagnoses for the assessment of atrophic gastritis[J].J Cancer Prev,2014,19(1):47-55.

Pasechnikov V D,Chukov S Z,Kotelevets S M,et al.The non-invasive diagnosis of precancerous changes of stomach mucosa[J].Rocz Akad Med Bialymst,2004,49:66-71.

Vaangnen H,Vauhkonen M,Helske T,et al.Non-endoscopic diagnosis of atrophic gastritis with a blood test.Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I:a muhicentre study[J].Eur J Gastroenterol Hepatol,2003,15:885-891.

中华医学会消化内镜分会.中国早期胃癌筛查及内镜诊治共识意见(2014年,长沙)[J].中华消化杂志,2014,34(7):433-448.

田珂,刘玉兰.自身免疫性胃炎的临床特点[J].中华消化杂志,2013,33(1):28-32.

Amedei A,Bergman M P,Appelmelk B J,et al.Molecular mimicry between Helicobacter pylori antigens and H+,K+--adenosine triphosphatase in human gastric autoimmunity[J].J Exp Med,2003,198(8):1147-1156.

Annibale B,Negrini R,Caruana P,et al.Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection[J].Helicobacter,2001,6(3):225-233.

Bergman M P,Amedei A,D'Elios M M,et al.Characterization of H+,K+-ATPase T cell epitopes in human autoimmune gastritis[J].Eur J Immunol,2003,33(2):539-545.

Kimura K,Takemoto T.An endoscopic recognition of the atrophic border and its significance in chronic gastritis[J].Endoscopy,1969,1:87-97.

Valenzuela M A,Canales J,Corvalán A H,et al.Helicobacter pylori-induced inflammation and epigenetic changes during gastric carcinogenesis[J].World J Gastroenterol,2015,21(45):12742-12756.

Sugano K,Tack J,Kuipers E J,et al.Faculty members of Kyoto Global Consensus Conference.Kyoto global consensus report on Helicobacter pylori gastritis[J].Gut,2015,64(9):1353-1367.

Atherton J C.The pathogenesis of Helicobacter pyloriinduced gastro-duodenal diseases[J].Annu Rev Pathol,2006,1:63-96.

Adamu M A,Weck M N,Rothenbacher D,et al.Incidence and risk factors for the development of chronic atrophic gastritis:five year follow-up of a populationbased cohort study[J].Int J Cancer,2011,128(7):1652-1658.

Craanen M E,Dekker W,Blok P,et al.Intestinal metaplasia and Helicobacter pylori:an endoscopic bioptic study of the gastric antrum[J].Gut,1992,33(1):16-20.

Nakajima T,Enomoto S,Yamashita S,et al.Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication[J].JGastroenterol,2010,45(1):37-44.

Nakajima T,Maekita T,Oda I,et al.Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers[J].Cancer Epidemiol Biomarkers Prev,2006,15(11):2317-2321.

Watanabe T,Tada M,Nagai H,et al.Helicobacter pylori infection induces gastric cancer in mongolian gerbils[J].Gastroenterology,1998,115(3):642-648.

Honda S,Fujioka T,Tokieda M,et al.Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils[J].Cancer Res,1998,58(19):4255-4259.

Masuyama H,Yoshitake N,Sasai T,et al.Relationship between the degree of endoscopic atrophy of the gastric mucosa and carcinogenic risk[J].Digestion,2015,91(1):30-36.

Pharoah P D,Guilford P,Caldas C.International Gastric Cancer Linkage Consortium.Incidence of gastric cancer and breast cancer in CDH1(E-cadherin)mutation carriers from hereditary diffuse gastric cancer families[J].Gastroenterology,2001,121(6):1348-1353.

Fitzgerald R C,Hardwick R,Huntsman D,et al.International Gastric Cancer Linkage Consortium.Hereditary diffuse gastric cancer:updated consensus guidelines for clinical management and directions for future research[J].J Med Genet,2010,47(7):436-444.

Watson P,Vasen H F,Mecklin J P,et al.The risk of extra-colonic,extra-endometrial cancer in the Lynch syndrome[J].Int J Cancer,2008,123(2):444-449.

Capelle L G,Van Grieken N C,Lingsma H F,et al.Risk and epidemiological time trends of gastric cancer in Lynch syndrome carriers in the Netherlands[J].Gastroenterology,2010,138(2):487-492.

Yaghoobi M,Bijarchi R,Narod S A.Family history and the risk of gastric cancer[J].Br J Cancer,2010,102(2):237-242.

Park Y H,Kim N.Review of atrophic gastritis and intestinal metaplasia as a premalignant lesion of gastric cancer[J].J Cancer Prev,2015,20(1):25-40.

Eto K,Ohyama S,Yamaguchi T,et al.Familial clustering in subgroups of gastric cancer stratified by histology,age group and location[J].Eur J Sur Oncol,2006,32(7):743-748.

Bernini M,Barbi S,Roviello F,et al.Family history of gastric cancer:a correlation between epidemiologic findings and clinical data[J].Gastric Cancer,2006,9(1):9-13.

Rokkas T,Sechopoulos P,Pistiolas D,et al.Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients:a meta-analysis[J].Eur J Gastroenterol Hepatol,2010,22(9):1128-1133.

Rugge M,Genta R M.Staging and grading of chronicgastritis[J].Hum Pathol,2005,36(3):228-233.

Rugge M,Meggio A,Pennelli G,et al.Gastritis staging in clinical practice:the OLGA staging system[J].Gut,2007,56(5):631-636.

Rugge M,Correa P,Di Mario F,et al.OLGA staging for gastritis:a tutorial[J].Dig Liver Dis,2008,40(8):650-658.

Capelle L G,de Vries A C,Haringsma J,et al.The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis[J].Gastrointest Endosc,2010,71(7):1150-1158.

Rugge M,de Boni M,Pennelli G,et al.Gastritis OL-GA-staging and gastric cancer risk:a twelve-year clinico-pathological follow-up study[J].Aliment Pharmacol Ther,2010,31(10):1104-1111.

Cho S J,Choi I J,Kook M C,et al.Staging of intestinal-and diffuse-type gastric cancers with the OLGAand OLGIM staging systems[J].Aliment Pharmacol Ther,2013,38(10):1292-1302.

Helicobacter and Cancer Collaborative Group.Gastric cancer and Helicobacter pylori:a combined analysis of 12 case control studies nested within prospective cohorts[J].Gut,2001,49(3):347-353.

Hsu P I,Lai K H,Hsu P N,et al.Helicobacter pylori infection and the risk of gastric malignancy[J].Am JGastroenterol,2007,102(4):725-730.

Yoon S B,Park J M,Lim C H,et al.Effect of Helicobacter pylori eradication on metachronous gastric cancer after endoscopic resection of gastric tumors:a metaanalysis[J].Helicobacter,2014,19(4):243-248.

Matsuo T,Ito M,Takata S,et al.Low prevalence of Helicobacter pylori-negative gastric cancer among Japanese[J].Helicobacter,2011,16(6):415-419.

Asaka M,Kato M,Sakamoto N.Roadmap to eliminate gastric cancer with Helicobacter pylori eradication and consecutive surveillance in Japan[J].J Gastroenterol,2014,49(1):1-8.

Graham D Y.Roadmap for elimination of gastric cancer in Korea[J].Korean J Intern Med,2015,30(2):133-139.

Tu H,Sun L,Dong X,et al.Temporal changes in serum biomarkers and risk for progression of gastric precancerous lesions:A longitudinal study[J].Int J Cancer,2015,136(2):425-434.

Yanaoka K,Oka M,Mukoubayashi C,et al.Cancer high-risk subjects identified by serum pepsinogen tests:outcomes after 10-year follow-up in asymptomatic middle-aged males[J].Cancer Epidemiol Biomarkers Prev,2008,17:838-845.

Miki K.Gastric cancer screening by combined assay for serum anti-Helicobacter pylori IgG antibody and serum pepsinogen levels-"ABC method"[J].Proc Jpn Acad Ser B Phys Biol Sci,2011,87(7):405-414.

Yamaguchi Y,Nagata Y,Hiratsuka R,et al.Gastric Cancer Screening by Combined Assay for Serum AntiHelicobacter pylori IgG Antibody and Serum Pepsinogen Levels-The ABC Method[J].Digestion,2016,93(1):13-18.

Yoshida T,Kato J,Inoue I,et al.Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer[J].Int J Cancer,2014,134:1445-1457.

王霄腾,蔡利军,吕宾.血清幽门螺杆菌抗体联合胃蛋白酶原检测在胃癌和癌前病变筛查中的应用[J].中华消化杂志,2016,36(9):582-587.

Uedo N,Ishihara R,Iishi H,et al.A new method of diagnosing gastric intestinal metaplasia:narrow-band imaging with magnifying endoscopy[J].Endoscopy,2006,38(8):819-824.

Savarino E,Corbo M,Dulbecco P,et al.Narrow-band imaging with magnifying endoscopy is accurate for detecting gastric intestinal metaplasia[J].World J Gastroenterol,2013,19(17):2668-2675.

Li W B,Zuo X L,Li C Q,et al.Diagnostic value of confocal laser endomicroscopy for gastric superficial cancerous lesions[J].Gut,2011,60(3):299-306.

中华中医药学会脾胃病分会.慢性萎缩性胃炎中医诊疗共识意见[J].中医杂志,2010,51(8):749-753.

张滨.从络病学说探讨慢性萎缩性胃炎[J].山西中医,2009,25(8):58-59.

孙仁,宋蓓,刘小军.李东垣升清降浊理论在慢性萎缩性胃炎治疗中的应用[J].辽宁中医杂志,2008,35(10):1468-1469.

郑保平.慢性萎缩性胃炎及其癌前病变的病机和证治探讨[J].江苏中医药,2010,42(1):8-9.

魏玉霞.慢性萎缩性胃炎近10年中医文献研究[D].北京:北京中医药大学,2012.

Kobayashi M,Tsubono Y,Sasazuki S,et al.Vegetables,fruit and risk of gastric cancer in Japan:a 10-year follow-up of the JPHC Study Cohort I[J].Int J Cancer,2002,102(1):39-44.

Lee K W,Lee H J,Surh Y J,et al.Vitamin C and cancer chemoprevention:reappraisal[J].Am J Clin Nutr,2003,78(6):1074-1078.

Kim D S,Lee M S,Kim Y S,et al.Effect modification by vitamin C on the relation between gastric cancer and Helicobacter pylori[J].Eur J Epidemiol,2005,20(1):67-71.

van den Brandt P A,Goldbohm R A.Nutrition in the prevention of gastrointestinal cancer[J].Best Pract Res Clin Gastroenterol,2006,20(3):589-603.

Chinese Society of Gastroenterology,Chinese Study Group on Helicobacter pylori,Liu W Z,et al.Fourth Chinese National Consensus Report on the management of Helicobacter pylori infection[J].J Dig Dis,2013,14(5):211-221.

Rokkas T,Pistiolas D,Sechopoulos P,et al.The longterm impact of Helicobacter pylori eradication on gastric histology:a systematic review and meta-analysis[J].Helicobacter,2007,(Suppl 2):32-38.

Wang J,Xu L,Shi R,et al.Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication:a meta-analysis[J].Digestion,2011,83(4):253-260.

Kong Y J,Yi H G,Dai J C,et al.Histological changes of gastric mucosa after Helicobacter pylori eradication:a systematic review and meta-analysis[J].World JGastroenterol,2014,20(19):5903-5911.

de Vries A C,Haringsma J,de Vries R A,et al.The use of clinical,histologic,and serologic parameters to predict the intragastric extent of intestinal metaplasia:a recommendation for routine practice[J].Gastrointest Endosc,2009,70(1):18-25.

Lu B,Chen M T,Fan Y H,et al.Effects of Helicobacter pylori eradication on atrophic gastritis and intestinal metaplasia:a 3-year follow-up study[J].World JGastroenterol,2005,11(41):6518-6520.

Correa P,Fontham E T,Bravo J C,et al.Chemoprevention of gastric dysplasia:randomized trial of antioxidant supplements and anti-helicobacter pylori therapy[J].J Natl Cancer Inst,2000,92(23):1881-1888.

Wong B C,Lam S K,Wong W M,et al.China Gastric Cancer Study Group.Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China:a randomized controlled trial[J].JAMA,2004,291(2):187-194.

Ma J L,Zhang L,Brown L M,et al.Fifteen-year effects of Helicobacter pylori,garlic,and vitamin treatments on gastric cancer incidence and mortality[J].J Natl Cancer Inst,2012,104(6):488-492.

Plummer M,Vivas J,Lopez G,et al.Chemoprevention of precancerous gastric lesions with antioxidant vitamin supplementation:a randomized trial in a highrisk population[J].J Natl Cancer Inst,2007,99(2):137-146.

You W C,Brown L M,Zhang L,et al.Randomized doubleblind factorial trial of three treatments to reduce the prevalence of precancerous gastric lesions[J].JNatl Cancer Inst,2006,98(14):974-983.

Zhang L J,Wang S Y,Huo X H,et al.Anti-Helicobacter pylori therapy followed by celecoxib on progression of gastric precancerous lesions[J].World J Gastroenterol,2009,15(22):2731-2738.

Yang H B,Cheng H C,Sheu B S,et al.Chronic celecoxib users more often show regression of gastric intestinal metaplasia after Helicobacter pylori eradication[J].Aliment Pharmacol Ther,2007,25(4):455-461.

Yanaoka K,Oka M,Yoshimura N,et al.Preventive effects of etodolac,a selective cyclooxygenase-2inhibitor,on cancer development in extensive metaplastic gastritis,a Helicobacter pylori-negative precancerous lesion[J].Int J Cancer,2010,126(6):1467-1473.

Leung W K,Ng E K,Chan F K,et al.Effects of longterm rofecoxib on gastric intestinal metaplasia:results of a randomized controlled trial[J].Clin Cancer Res,2006,12(15):4766-4772.

杨湘怡,吴云林,朱燕华,等.胃黏膜低级别上皮内瘤变的胃复春联用叶酸治疗及转归研究[J].内科理论与实践,2013,8(1):24-28.

朱亮亮,田金徽,拜争刚,等.胃复春治疗慢性萎缩性胃炎的系统评价[J].中国循证医学杂志,2009,9(1):81-87.

王婷婷,张月苗,张学智,等.荆花胃康胶丸联合PPI三联疗法对幽门螺杆菌阳性慢性萎缩性胃炎的效果:多中心随机对照临床研究[J].中华医学杂志,2013,93(44):3491-3495.

Tang X D,Zhou L Y,Zhang S T,et al.Randomized double-blind clinical trial of Moluodan for the treatment of chronic atrophic gastritis with dysplasia[J].Chin J Integr Med,2016,22(1):9-18.

De Luca L,Zagari R M,Pozzato P,et al.Measuring dyspepsia:a new severity index validated in Bologna[J].Dig Liver Dis,2004,36(12):806-810.

Fock K M,Talley N,Moayyedi P,et al.Asia-Pacific Gastric Cancer Consensus Conference.Asia-Pacific consensus guidelines on gastric cancer prevention[J].JGastroenterol Hepatol,2008,23(3):351-365.